Document 6wXLVZ1MkZEoG0REVEKOaovgR

on hepatic drug-metabolizing enzymes and porphyria related to contamination with chlorinated dibenzo-pdioxins and dibenzofurans. Biochem Pharm 1977; 26:1549-1557. 66. Calvert GM, Sweeney MH, Fingerhut MA, Homung RW, and Halperin WE. Evaluation of porphyria cutanea tarda in U.S. workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Am J Industrial Med 1994; 25:559-571. 65. Doss MO and Colombi AM. Chronic hepatic porphyria induced by chemicals: the example of dioxin. In Occupational and Environmental Chemical Hazards, Fao V, Emmett EA, Maroni M, and Colombi A. Ellis Horwood 1987. 67. Van Bergelin APJM, Fase KM, Van der Kolk J, Poiger H, Brouwer A, Seinen W, and Van den Berg M. Synergistic effect of 2,2',4,4',5,5'-Hexachlorobiphenyl and 2,3,6,7-tetrachlorobibenzodioxin on hepatic prophyrin levels in female Sprague-Dawley rats. In Organohalogen Compounds 25: 105-110, 1995. 68. Noweir MH and Pfitzer EA. Evaluation of Coproporphyrin in urine from workers exposed to lead. Amer Indust Hyg Assoc J 1970; x:492-500 69. Bombick DW, Matsumura G, Madhukar BV. Low density lipoprotein receptor activities in the hepatic plasma membrane of the guinea pig and rat. Biochem Biophys Res Comm 1984; 118:548-554. 70. Brewster DW and Matsumura F. 2,3,7,8-TCDD reduces lipoprotein lipase activity in the adipose tissue of the guinea pig. Biochem Biophys Res Comm 1984; 122:810-817. 71. Haring Sweeney M, Fingerhut MA, Arezzo JC, Hornung RW, and Conally B. Peripheral Neuropathy After Occupational Exposusre to 2,3,7,8-TCDD. Am J Industrial Med 1993; 23:845-858. 72. Klawans HL. Dystonia and Tremor Following Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin. Movement Disorders 1987; 2:255-261. 73. Fingerhut MA, Haring-Sweeney M, Patterson DG, Piacitelli LA, Morris JA, Marolow DA, Homung RW, Cameron LW, Connally LB, Needam LL, and Halperin WE. Levels of 2,3,7,8-TCDD in the 42 DSW 476038.1795 STLCOPCB4043944